KLACID 125mg / 5ml granules for oral suspension medication leaflet

J01FA09 clarithromycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins

Clarithromycin is an antibiotic used to treat a wide range of bacterial infections, including respiratory infections, skin infections, and ear infections. It belongs to the macrolide class and works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.

The medication is taken orally, usually in the form of tablets or suspension, and should be used as directed by your doctor. It is important to complete the full course of treatment, even if symptoms improve, to prevent the development of bacterial resistance.

Side effects may include nausea, diarrhea, abdominal pain, or changes in taste. In rare cases, severe allergic reactions, liver damage, or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases or cardiac arrhythmias, as these may affect the safety of clarithromycin use.

KLACID 125mg/5ml granules for oral suspension BGP PRODUCTS, clarithromycin

General data about KLACID 125mg / 5ml

Substance: clarithromycin

Date of last drug list: 10-04-2026

Commercial code: W62389002

Concentration: 125mg / 5ml

Pharmaceutical form: granules for oral suspension

Packing volume: 60ml

Product type: original

Price: 34.45 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ABBVIE S.R.L. - ITALIA

Holder: MYLAN ITALIA S.R.L. - ITALIA

Number: 8386/2015/01

Shelf life: 2 years-dupa ambalarea pt comercializard; dupa constituirea susp.: 28 days

Concentrations available for clarithromycin

125mg/5ml, 250mg, 250mg/5ml, 250mg/ml, 500mg

Compensation lists for KLACID 125mg / 5ml BGP PRODUCTS

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

34.45 RON

27.90 RON

6.55 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

34.45 RON

30.54 RON

3.91 RON

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

34.45 RON

30.54 RON

3.91 RON

NHP 6.4 (C2) - Cystic fibrosis

Price

Copayment

Patient

34.45 RON

30.54 RON

3.91 RON